Interleukin-17 levels correlate with poor prognosis and vascular endothelial growth factor concentration in the serum of patients with non-small cell lung cancer

被引:39
作者
Pan, Bo [1 ]
Che, Dehai [1 ]
Cao, Jingyan [1 ]
Shen, Jing [1 ]
Jin, Shi [1 ]
Zhou, Yongxu [2 ]
Liu, Fang [1 ]
Gu, Kuo [1 ]
Man, Yingchun [3 ]
Shang, Lihua [1 ]
Yu, Yan [1 ]
机构
[1] Harbin Med Univ, Canc Hosp, Dept Med Oncol, Harbin 150081, Heilongjiang Pr, Peoples R China
[2] Harbin Med Univ, Affiliated Hosp 4, Dept Gen Surg, Harbin 150081, Heilongjiang Pr, Peoples R China
[3] Second Hosp Heilongjiang Prov, Gen Hosp Heilongjiang Prov Reclamat Headquarter, Dept Med Oncol, Harbin, Peoples R China
基金
中国国家自然科学基金;
关键词
Angiogenesis; IL-17; non-small cell lung cancer; prognosis; VEGF; TUMOR ANGIOGENESIS; T-CELLS; HEPATOCELLULAR-CARCINOMA; PROMOTES ANGIOGENESIS; COLORECTAL-CARCINOMA; MULTIPLE-MYELOMA; VEGF PRODUCTION; GASTRIC-CANCER; BREAST-CANCER; IL-17;
D O I
10.3109/1354750X.2015.1068853
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Objective: The aim of this study was to explore the clinical role of serum interleukin-17 in patients with non-small-cell lung cancer (NSCLC). Materials and method: IL-17 expression and microvessel density (MVD) were measured via immunohistochemistry in 58 NSCLC tissues. Serum IL-17 and VEGF levels in NSCLC patients (n = 43) and healthy controls (n = 37) were analyzed via enzyme-linked immunosorbent assay. Results: Serum IL-17 was elevated and the levels positively correlated with VEGF concentration in NSCLC patients. Multivariate analyses revealed that serum IL-17 levels were an independent prognostic factor in NSCLC. Conclusion: IL-17 may play a role in NSCLC progression by promoting angiogenesis.
引用
收藏
页码:232 / 239
页数:8
相关论文
共 42 条
  • [1] Serum interleukin-17 and its relationship to angiogenic factors in multiple myeloma
    Alexandrakis, Michael G.
    Pappa, Constantina A.
    Miyakis, Spiros
    Sfiridaki, Aikaterini
    Kafousi, Maria
    Alegakis, Athanassios
    Stathopoulos, Efstathios N.
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2006, 17 (06) : 412 - 416
  • [2] Microenvironment-Derived IL-1 and IL-17 Interact in the Control of Lung Metastasis
    Carmi, Yaron
    Rinott, Gal
    Dotan, Shahar
    Elkabets, Moshe
    Rider, Peleg
    Voronov, Elena
    Apte, Ron N.
    [J]. JOURNAL OF IMMUNOLOGY, 2011, 186 (06) : 3462 - 3471
  • [3] T helper 17 cells play a critical pathogenic role in lung cancer
    Chang, Seon Hee
    Mirabolfathinejad, Seyedeh Golsar
    Katta, Harshadadevi
    Cumpian, Amber M.
    Gong, Lei
    Caetano, Mauricio S.
    Moghaddam, Seyed Javad
    Dong, Chen
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (15) : 5664 - 5669
  • [4] Increased IL-17-producing cells correlate with poor survival and lymphangiogenesis in NSCLC patients
    Chen, Xi
    Wan, Jin
    Liu, Jiankun
    Xie, Wei
    Diao, Xinwei
    Xu, Jianping
    Zhu, Bo
    Chen, Zhengtang
    [J]. LUNG CANCER, 2010, 69 (03) : 348 - 354
  • [5] Inflammation and cancer
    Eiro, Noemi
    Vizoso, Francisco J.
    [J]. WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2012, 4 (03): : 62 - 72
  • [6] VEGF and the quest for tumour angiogenesis factors
    Ferrara, N
    [J]. NATURE REVIEWS CANCER, 2002, 2 (10) : 795 - 803
  • [7] The biology of vascular endothelial growth factor
    Ferrara, N
    DavisSmyth, T
    [J]. ENDOCRINE REVIEWS, 1997, 18 (01) : 4 - 25
  • [8] An overview of IL-17 function and signaling
    Gaffen, Sarah L.
    [J]. CYTOKINE, 2008, 43 (03) : 402 - 407
  • [9] Locally advanced non-small cell lung cancer: The past, present, and future
    Govindan, Ramaswamy
    Bogart, Jeffrey
    Vokes, Everett E.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (08) : 917 - 928
  • [10] The hallmarks of cancer A long non-coding RNA point of view
    Gutschner, Tony
    Diederichs, Sven
    [J]. RNA BIOLOGY, 2012, 9 (06) : 703 - 719